E-Newsletter
Subscribe Now
  ABOUT US   |   CONTACT US   |   SUBSCRIPTION CENTRE   |   ADVERTISE   |   SITEMAP
MAGAZINE
Current Issue
Past Issues
Digital Magazine
News Archives
Web Exclusives
 
MARKETPLACE
Job Board
Classifieds
Product News
COMMUNITY
Blog
Events
 
RESOURCES
E-Newsletter
Links
Sitemap
 
Novozymes acquires Iogen's enzyme business
Written by Novozymes   
January 31, 2013, Ottawa, ON – Novozymes has acquired Iogen Bio-Products, the industrial enzyme business of Ottawa-based Iogen Corporation for $67.5 million (CDN).

The deal provides Novozymes with all commercial rights to Iogen Bio-Products’ existing product portfolio, pipeline, facilities and know-how. Novozymes acquires all of Iogen Corporation’s industrial enzyme business. The acquisition does not include the purchase of assets that relate to Iogen Corporation’s bioenergy process technologies.

Iogen Bio-Products, which entered the industrial enzyme industry in 1991, produces and sells enzymes for the pulp & paper, textile, grain-processing and animal feed industries. The company has close to 70 employees and sells more than 20 products globally.

“Iogen Bio-Products is a good fit for Novozymes,” said Andrew Fordyce, VP of Global Enzyme Sales and Customer Solutions at Novozymes. “We get a number of products that complement our existing product portfolio and welcome a talented group of employees who are very good at developing and producing industrial enzymes.”

Closing of the acquisition is anticipated late February 2013, awaiting finalization of corporate formalities.
 
Submit News Release